Davis Polk advised AstraZeneca PLC in connection with its SEC-registered shelf takedown of $850 million aggregate principal amount of 3.500% notes due 2023, $400 million aggregate…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now